Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Roche Holding AG | 2.34% | $365.43K | CHF294.92B | 46.36% | 73 Outperform | |
| HSBC Holdings | 2.19% | $341.84K | £218.16B | 44.94% | 80 Outperform | |
| Novartis AG | 2.14% | $335.13K | CHF244.33B | 31.88% | 80 Outperform | |
| BHP Group Ltd | 1.95% | $305.50K | AU$267.82B | 44.06% | 68 Neutral | |
| BNP Paribas | 1.74% | $272.22K | €102.04B | 33.50% | 77 Outperform | |
| ASML Holding NV | 1.69% | $264.04K | €458.08B | 67.61% | 76 Outperform | |
| Rio Tinto | 1.68% | $263.03K | £120.85B | 46.72% | 82 Outperform | |
| Sumitomo Mitsui Financial Group | 1.63% | $254.38K | ¥21.99T | 48.74% | 77 Outperform | |
| ABB Ltd | 1.61% | $251.50K | kr1.49T | 35.01% | 78 Outperform | |
| Iberdrola | 1.60% | $250.49K | €134.19B | 49.54% | 67 Neutral |